These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 29470731)

  • 1. Sacral neuromodulation versus personalized conservative treatment in patients with idiopathic slow-transit constipation: study protocol of the No.2-trial, a multicenter open-label randomized controlled trial and cost-effectiveness analysis.
    Heemskerk SCM; Rotteveel AH; Benninga MA; Baeten CIM; Masclee AAM; Melenhorst J; van Kuijk SMJ; Dirksen CD; Breukink SO
    Int J Colorectal Dis; 2018 Apr; 33(4):493-501. PubMed ID: 29470731
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sacral Neuromodulation Versus Conservative Treatment for Refractory Idiopathic Slow-transit Constipation: The Randomized Clinical No.2-Trial.
    Heemskerk SCM; Dirksen CD; van Kuijk SMJ; Benninga MA; Baeten CIM; Masclee AAM; Melenhorst J; Breukink SO
    Ann Surg; 2024 May; 279(5):746-754. PubMed ID: 37991178
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effectiveness, safety and cost-effectiveness of sacral neuromodulation for idiopathic slow-transit constipation: a systematic review.
    Heemskerk SCM; van der Wilt AA; Penninx BMF; Kleijnen J; Melenhorst J; Dirksen CD; Breukink SO
    Colorectal Dis; 2024 Mar; 26(3):417-427. PubMed ID: 38247282
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost-effectiveness of sacral neuromodulation for chronic refractory constipation in children and adolescents: a Markov model analysis.
    van der Wilt AA; Groenewoud HHM; Benninga MA; Dirksen CD; Baeten CGMI; Bouvy ND; Melenhorst J; Breukink SO
    Colorectal Dis; 2017 Nov; 19(11):1013-1023. PubMed ID: 28834055
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term outcome of intractable constipation treated by sacral neuromodulation: a comparison between children and adults.
    Janssen PTJ; Meyer YM; Van Kuijk SMJ; Benninga MA; Stassen LPS; Bouvy ND; Melenhorst J; Breukink SO
    Colorectal Dis; 2018 Feb; 20(2):134-143. PubMed ID: 28782277
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sacral nerve stimulation for intractable constipation.
    Kamm MA; Dudding TC; Melenhorst J; Jarrett M; Wang Z; Buntzen S; Johansson C; Laurberg S; Rosen H; Vaizey CJ; Matzel K; Baeten C
    Gut; 2010 Mar; 59(3):333-40. PubMed ID: 20207638
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sacral neuromodulation therapy: a promising treatment for adolescents with refractory functional constipation.
    van Wunnik BP; Peeters B; Govaert B; Nieman FH; Benninga MA; Baeten CG
    Dis Colon Rectum; 2012 Mar; 55(3):278-85. PubMed ID: 22469794
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sacral neuromodulation in children and adolescents with chronic constipation refractory to conservative treatment.
    van der Wilt AA; van Wunnik BP; Sturkenboom R; Han-Geurts IJ; Melenhorst J; Benninga MA; Baeten CG; Breukink SO
    Int J Colorectal Dis; 2016 Aug; 31(8):1459-66. PubMed ID: 27294660
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sacral nerve stimulation in slow-transit constipation: effectiveness at 5-year follow-up.
    Schiano di Visconte M; Pasquali A; Cipolat Mis T; Brusciano L; Docimo L; Bellio G
    Int J Colorectal Dis; 2019 Sep; 34(9):1529-1540. PubMed ID: 31309325
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sacral neuromodulation for constipation and fecal incontinence in children and adolescents - study protocol of a prospective, randomized trial on the application of invasive vs. non-invasive technique.
    Besendörfer M; Kirchgatter A; Carbon R; Weiss C; Müller H; Matzel KE; Diez S
    Trials; 2024 Mar; 25(1):210. PubMed ID: 38515199
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Short-term effects of magnetic sacral dermatome stimulation for idiopathic slow transit constipation: sham-controlled, cross-over pilot study.
    Lee KJ; Kim JH; Cho SW
    J Gastroenterol Hepatol; 2006 Jan; 21(1 Pt 1):47-53. PubMed ID: 16706811
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CON-COUR study: Interferential therapy in the treatment of chronic constipation in adults: study protocol for a randomized controlled trial.
    Vitton V; Benezech A; Honoré S; Sudour P; Lesavre N; Auquier P; Baumstarck K
    Trials; 2015 May; 16():234. PubMed ID: 26012788
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost-effectiveness of sacral neuromodulation compared to botulinum neurotoxin a or continued medical management in refractory overactive bladder.
    Arlandis S; Castro D; Errando C; Fernández E; Jiménez M; González P; Crespo C; Staeuble F; Rodríguez JM; Brosa M
    Value Health; 2011; 14(2):219-28. PubMed ID: 21402292
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of slow-transit constipation with sacral nerve modulation.
    Naldini G; Martellucci J; Moraldi L; Balestri R; Rossi M
    Colorectal Dis; 2010 Nov; 12(11):1149-52. PubMed ID: 19843118
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sacral Nerve Stimulation Fails to Offer Long-term Benefit in Patients With Slow-Transit Constipation.
    Patton V; Stewart P; Lubowski DZ; Cook IJ; Dinning PG
    Dis Colon Rectum; 2016 Sep; 59(9):878-85. PubMed ID: 27505117
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuromodulation for constipation: sacral and transcutaneous stimulation.
    van Wunnik BP; Baeten CG; Southwell BR
    Best Pract Res Clin Gastroenterol; 2011 Feb; 25(1):181-91. PubMed ID: 21382589
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term outcome of sacral neuromodulation for chronic refractory constipation.
    Maeda Y; Kamm MA; Vaizey CJ; Matzel KE; Johansson C; Rosen H; Baeten CG; Laurberg S
    Tech Coloproctol; 2017 Apr; 21(4):277-286. PubMed ID: 28429130
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment efficacy of sacral nerve stimulation in slow transit constipation: a two-phase, double-blind randomized controlled crossover study.
    Dinning PG; Hunt L; Patton V; Zhang T; Szczesniak M; Gebski V; Jones M; Stewart P; Lubowski DZ; Cook IJ
    Am J Gastroenterol; 2015 May; 110(5):733-40. PubMed ID: 25895520
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Sacral neuromodulation in the treatment of intractable constipation].
    Zheng J; Li S; Nie Y; Sun H; Wang M; Dai Y; Zhao H; Pang G; Wu G; Zhao Q
    Zhonghua Wei Chang Wai Ke Za Zhi; 2014 Dec; 17(12):1175-8. PubMed ID: 25529946
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Noninvasive Sacral Neuromodulation in Children and Adolescents: A Case-Control Study of Patients With Chronic Refractory Constipation.
    Diez S; Kirchgatter A; Adam D; Füldner A; Müller H; Matzel KE; Besendörfer M
    Neuromodulation; 2023 Dec; 26(8):1858-1866. PubMed ID: 36207226
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.